Inhibition of ZIP13 function enhances beige adipocyte biogenesis and thermogenesis, highlighting the potential of ZIP13 as a therapeutic target for obesity and metabolic syndrome. The gene discussed is SLC39A13; the disease is obesity due to melanocortin 4 receptor deficiency.